CX Institutional’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$207K Buy
5,597
+837
+18% +$30K 0.01% 738
2026
Q2
$158K Sell
4,760
-25,289
-84% -$787K ﹤0.01% 785
2026
Q1
$907K Buy
30,049
+25,217
+522% +$809K 0.03% 353
2025
Q4
$154K Sell
4,832
-996
-17% -$30.9K ﹤0.01% 773
2025
Q3
$171K Buy
5,828
+5,294
+991% +$153K 0.01% 735
2025
Q2
$16K Sell
534
-2,052
-79% -$58.4K ﹤0.01% 992
2025
Q1
$77K Buy
+2,586
New +$78.4K ﹤0.01% 780
2023
Q3
– Sell
-38,260
Closed -$1.14M – 536
2023
Q2
$1.14M Buy
+38,260
New +$1.12M 0.06% 260
2023
Q1
– Sell
-8,810
Closed -$254K – 569
2022
Q4
$254K Sell
8,810
-34,980
-80% -$974K 0.02% 462
2022
Q3
$1.1M Buy
+43,790
New +$1.2M 0.08% 244

Other funds holding RSPH

CX Institutional's RSPH Position: Q3 2026 in Review

CX Institutional increased its Invesco S&P 500 Equal Weight Health Care ETF (RSPH) stake by 18% in Q3 2026, buying an estimated $30K and bringing the position to 5,597 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #738.

CX Institutional first reported a position in RSPH in Q3 2022 and has held it in 10 quarters since. The position peaked at $1.14M in Q2 2023. 10 funds tracked by Wall St. Rank hold RSPH as of Q3 2026.

  • CX Institutional held 5,597 shares of Invesco S&P 500 Equal Weight Health Care ETF worth $207K as of Q3 2026.
  • CX Institutional bought 837 Invesco S&P 500 Equal Weight Health Care ETF shares in Q3 2026, an estimated $30K.
  • Invesco S&P 500 Equal Weight Health Care ETF made up 0.01% of CX Institutional's portfolio in Q3 2026, its #738 holding.
  • CX Institutional first reported a position in Invesco S&P 500 Equal Weight Health Care ETF in Q3 2022 and has held it in 10 quarters since.
  • CX Institutional's Invesco S&P 500 Equal Weight Health Care ETF position peaked at $1.14M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight Health Care ETF as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.